AGENUS INC(AGEN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,397 of 2,961 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
AGEN Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for AGENUS INC (AGEN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AGEN at 53.3/100 on a 32-signal composite quality model, placing it at rank #1,397 of 2,961 stocks — the top half of the AI-ranked universe. AGEN scores in the top quartile across balance sheet strength (99.5), profitability (99.0), institutional flow (83.1). Areas of concern include free cash flow (7.5) and earnings quality (8.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AGENUS INC reports quarterly revenue of $34.5M, net income of $-567.0K, free cash flow of $-31.2M. Top institutional holders of AGEN by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. AGEN trades on the Nasdaq exchange and files with the SEC under CIK 1098972. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AGENUS INC directly from SEC EDGAR. AGENUS INC's 13F Pro composite quality score has ranged between 10 and 53 since 2021, currently 53.3 — an improving long-term trajectory across 69 quarterly and live scoring snapshots.
Revenue
Q2 2026
$34.5M
Net Income
Q2 2026
$-567.0K
Free Cash Flow
Q2 2026
$-31.2M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+10.4% YoYNet Income
+98.7% YoYOperating Income
+83.3% YoYEPS (Diluted)
+100.0% YoYTotal Assets
+0.2% YoYTotal Debt
+149.0% YoYOp. Cash Flow
+51.2% YoYFree Cash Flow
+51.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $114.2M +10.4% | $103.5M -33.8% | $156.3M +59.5% | $98.0M -66.8% | $295.7M +235.3% | $88.2M |
| Net Income | $-3.1M +98.7% | $-232.3M +9.8% | $-257.4M | — | — | — |
| Operating Income | $-20.2M +83.3% | $-120.5M +24.5% | $-159.5M +11.1% | $-179.4M -796.9% | $25.7M +122.0% | $-117.2M |
| EPS (Diluted) | $0.00 +100.0% | $-10.59 +23.0% | $-13.75 +12.1% | $-15.64 -14118.2% | $-0.11 +89.5% | $-1.05 |
| Total Assets | $226.8M +0.2% | $226.3M -27.9% | $313.9M -24.1% | $413.6M -11.2% | $466.0M +117.2% | $214.5M |
| Total Debt | $89.3M +149.0% | $35.9M +177.8% | $12.9M -1.9% | $13.2M -2.9% | $13.6M -31.3% | $19.7M |
| Operating Cash Flow | $-77.2M +51.2% | $-158.3M +29.4% | $-224.2M -27.8% | $-175.4M -1828.7% | $10.1M +107.3% | $-139.1M |
| Free Cash Flow | $-77.2M +51.4% | $-158.9M +32.1% | $-234.2M -2.5% | $-228.4M -865.1% | $-23.7M +83.4% | $-142.6M |
Get alerted when AGEN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for AGENUS INC including:
Top Institutional Holders of AGEN
BlackRock, Inc.
$7.8M2,564,884 shVANGUARD CAPITAL MANAGEMENT LLC
$5.1M1,676,096 shVANGUARD PORTFOLIO MANAGEMENT LLC
$4.4M1,427,587 shSiren, L.L.C.
$3.3M1,064,250 shGEODE CAPITAL MANAGEMENT, LLC
$3.2M1,035,040 shMACKENZIE FINANCIAL CORP
$2.2M714,175 shGOLDMAN SACHS GROUP INC
$1.4M448,383 shMARSHALL WACE, LLP
$1.3M439,621 shRAYMOND JAMES FINANCIAL INC
$1.3M430,078 shGLOBEFLEX CAPITAL L P
$1.3M418,581 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $7.8M | 2,564,884 |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.1M | 1,676,096 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.4M | 1,427,587 |
| Siren, L.L.C. | $3.3M | 1,064,250 |
| GEODE CAPITAL MANAGEMENT, LLC | $3.2M | 1,035,040 |
| MACKENZIE FINANCIAL CORP | $2.2M | 714,175 |
| GOLDMAN SACHS GROUP INC | $1.4M | 448,383 |
| MARSHALL WACE, LLP | $1.3M | 439,621 |
| RAYMOND JAMES FINANCIAL INC | $1.3M | 430,078 |
| GLOBEFLEX CAPITAL L P | $1.3M | 418,581 |
Companies Similar to AGEN
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
ARVINAS, INC.
BIOLIFE SOLUTIONS INC
Guardian Pharmacy Services, Inc.
KYNTRA BIO, INC.
MeiraGTx Holdings plc
Strata Critical Medical, Inc.
AtriCure, Inc.
BillionToOne, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put AGEN on your watchlist
Track score changes the day AGENUS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AGEN a good stock to buy?
13F Pro's AI-powered analysis of AGENUS INC (AGEN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AGEN are available on the AGEN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AGEN is classified as a small company.
Which hedge funds own AGEN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AGEN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AGENUS INC's investment landscape.